Galvusmet Vidagliptin 50mg+ Metformin 850mg 1 Tablet [Prescription Required]

REMINDER: A doctor's prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to,OnlinePharmacy@watsons.com.ph,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.

Adjunct to diet & exercise to improve glycemic control in patients with type 2 DM as monotherapy. In combination with metformin/sulfonylurea (SU)/thiazolidinedione (TZD) alone when diet & exercise do not result in adequate glycemic control. In triple combination with SU & metformin when diet & exercise plus dual therapy do not provide adequate glycemic control. In combination with insulin (with or without metformin) when diet, exercise & stable dose of insulin do not result in adequate glycemic control. Initial combination with metformin in patients with type 2 DM whose diabetes is not adequately controlled by diet &amp, exercise alone

*This product is VAT-exempt. Price displayed is without VAT.

Origin

Turkey

Product Usage

Should be taken with food.

Ingredients

Each tablet contains Vildagliptin 50 mg and Metformin hydrochloride 850 mg.

Warnings

Special precautions: Not be used in treatment of type 1 DM and diabetic ketoacidosis. Risk of lactic acidosis and hypoglycemia; may be temporarily withheld in case of loss of glycemic control. Risk of decreased vit B12 serum levels. Concomitant use with drugs affecting renal function or metformin HCl disposition. Pre-treatment ALT or AST >2.5 x ULN. Perform liver function test prior to treatment initiation at 3-mth intervals during the 1st yr and periodically thereafter. Avoid excessive alcohol intake. Discontinue use in case of hypoxemia; undergoing surgical procedure and radiologic studies involving intravascular administration of iodinated contrast materials. withdraw use if an increase in AST/ALT ≥3 x ULN and do not reinitiate. Monitor renal function. Hepatic and renal impairment. Pregnancy and lactation. Childn <18 yr. Elderly.

Width

1

Height

1

Depth

1